Roferon (rIFN-alpha 2a) is more immunogenic than intron A (rIFN-alpha 2b) in patients with chronic myelogenous leukemia (Q72412702)
Jump to navigation
Jump to search
scientific article published on 01 August 1994
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Roferon (rIFN-alpha 2a) is more immunogenic than intron A (rIFN-alpha 2b) in patients with chronic myelogenous leukemia |
scientific article published on 01 August 1994 |
Statements
Roferon (rIFN-alpha 2a) is more immunogenic than intron A (rIFN-alpha 2b) in patients with chronic myelogenous leukemia (English)
P Von Wussow
R Hehlmann
T Hochhaus
D Jakschies
K U Nolte
O Prümmer
H Ansari
J Hasford
H Heimpel
1 August 1994